Not Yet RecruitingNot Applicable

Combination Therapy of Imiquimod 5%Cream and Cryotherapy vs Monotherapy for Common Warts:Randomized Comparative Trial.

60 participantsStarted 2025-07-01

Plain-language summary

To assess the clinical efficacy and safety of topical imiquimod 5% cream combined with cryotherapy versus either of theme alone for the treatment of common warts by clinical and dermoscopic assessments.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with common warts diagnosed clinically and by dermoscopy. * Patients older than 18years old. Exclusion Criteria: * Pregnancy and lactation. * Immunosuppression or being under any kind of treatment causing * absolute or relative immunosuppression. * Patients with chronic systemic diseases. * All cases of bleeding tendency or using anticoagulants. * Concurrent use of systemic or topical treatments of warts in the last 4 weeks.

What they're measuring

Complete clearance rate of common warts.

Timeframe: 12 weeks

Trial details

NCT IDNCT06973473

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-07-01

Contact for this trial

Eman Fathy Ahmed Lecturer of Dermatology, Venereology and Andrology Faculty of

00201002258614 dr.emanfathy@aun.edu.eg

View on ClinicalTrials.gov More Warts trials